4th Quarter - Report

KING & SPALDING LLP for AMARIN PHARMA, INC.

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Advocacy related to cardiovascular health and reduction of residual risk after statins

LobbyistCovered position, as disclosed
MICHAEL A ANDREWS Member, U.S. House of Representatives, 1980-1994
JEANNINE M BENDER Staff, Rep. Barton
ALEXANDER ("ANDER") M. CRENSHAW U.S. Representative (FL-04), 2001-2017
DAVID JOSEPH FARBER —
ALLISON F KASSIR —

Contacted: Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.